Literature DB >> 18339708

Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.

Mia D Reed-Tsur1, Antonio De la Vieja, Christopher S Ginter, Nancy Carrasco.   

Abstract

I(-) is actively transported into thyrocytes via the Na+/I(-) symporter (NIS), a key glycoprotein located on the basolateral plasma membrane. The cDNA encoding rat NIS was identified in our laboratory, where an extensive structure/function characterization of NIS is being conducted. Several NIS mutants have been identified as causes of congenital I(-) transport defect (ITD), including V59E NIS. ITD is characterized by low thyroid I(-) uptake, low saliva/plasma I(-) ratio, hypothyroidism, and goiter and may cause mental retardation if untreated. Studies of other ITD-causing NIS mutants have revealed valuable information regarding NIS structure/function. V59E NIS was reported to exhibit as much as 30% of the activity of wild-type NIS. However, this observation was at variance with the patients' phenotype of total lack of activity. We have thoroughly characterized V59E NIS and studied several amino acid substitutions at position 59. We demonstrated that, in contrast to the previous report, V59E NIS is inactive, although it is properly targeted to the plasma membrane. Glu and all other charged amino acids or Pro at position 59 also yielded nonfunctional NIS proteins. However, I(-) uptake was rescued to different degrees by the other substitutions. Although the Km values for Na+ and I(-) were not altered in these active mutants, we found that the structural requirement for NIS function at position 59 is a neutral, helix-promoting amino acid. This result suggests that the region that contains V59 may be involved in intramembrane helix-helix interactions during the transport cycle without being in direct contact with the substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339708      PMCID: PMC2408800          DOI: 10.1210/en.2008-0027

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

1.  The mammary gland iodide transporter is expressed during lactation and in breast cancer.

Authors:  U H Tazebay; I L Wapnir; O Levy; O Dohan; L S Zuckier; Q H Zhao; H F Deng; P S Amenta; S Fineberg; R G Pestell; N Carrasco
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

2.  A novel peculiar mutation in the sodium/iodide symporter gene in spanish siblings with iodide transport defect.

Authors:  Shinji Kosugi; Hiroomi Okamoto; Aiko Tamada; F Sanchez-Franco
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

3.  Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.

Authors:  Orsolya Dohán; M Verónica Gavrielides; Christopher Ginter; L Mario Amzel; Nancy Carrasco
Journal:  Mol Endocrinol       Date:  2002-08

4.  Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity.

Authors:  Antonio De la Vieja; Mia D Reed; Christopher S Ginter; Nancy Carrasco
Journal:  J Biol Chem       Date:  2007-07-02       Impact factor: 5.157

5.  Five cases of absence of iodide concentrating mechanism.

Authors:  K Toyoshima; Y Matsumoto; M Nishida; H Yabuuchi
Journal:  Acta Endocrinol (Copenh)       Date:  1977-03

Review 6.  Congenital goiter with defective iodide transport.

Authors:  J Wolff
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

Review 7.  Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.

Authors:  A De La Vieja; O Dohan; O Levy; N Carrasco
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

Review 8.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.

Authors:  Orsolya Dohán; Antonio De la Vieja; Viktoriya Paroder; Claudia Riedel; Mona Artani; Mia Reed; Christopher S Ginter; Nancy Carrasco
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

9.  Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.

Authors:  Massimo Tonacchera; Patrizia Agretti; Giuseppina de Marco; Rossella Elisei; Anna Perri; Elena Ambrogini; Melissa De Servi; Claudia Ceccarelli; Paolo Viacava; Samuel Refetoff; Claudio Panunzi; Maria Luisa Manca Bitti; Paolo Vitti; Luca Chiovato; Aldo Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  2003-10       Impact factor: 3.478

10.  The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.

Authors:  Antonio De La Vieja; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2004-01-20       Impact factor: 5.285

View more
  18 in total

1.  The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.

Authors:  Viktoriya Paroder; Juan P Nicola; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2013-05-20       Impact factor: 5.285

Review 2.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

3.  Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS).

Authors:  Monika Paroder-Belenitsky; Matthew J Maestas; Orsolya Dohán; Juan Pablo Nicola; Andrea Reyna-Neyra; Antonia Follenzi; Ekaterina Dadachova; Sepehr Eskandari; L Mario Amzel; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

4.  Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).

Authors:  Wenjing Li; Juan Pablo Nicola; L Mario Amzel; Nancy Carrasco
Journal:  FASEB J       Date:  2013-05-06       Impact factor: 5.191

Review 5.  Defects of Thyroid Hormone Synthesis and Action.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-06       Impact factor: 4.741

6.  Na+ coordination at the Na2 site of the Na+/I- symporter.

Authors:  Giuseppe Ferrandino; Juan Pablo Nicola; Yuly E Sánchez; Ignacia Echeverria; Yunlong Liu; L Mario Amzel; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

7.  Conserved tyrosine in the first transmembrane segment of solute:sodium symporters is involved in Na+-coupled substrate co-transport.

Authors:  Sonia Mazier; Matthias Quick; Lei Shi
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

8.  The paradoxical lean phenotype of hypothyroid mice is marked by increased adaptive thermogenesis in the skeletal muscle.

Authors:  Rachel R Kaspari; Andrea Reyna-Neyra; Lara Jung; Alejandra Paola Torres-Manzo; Sandro M Hirabara; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-21       Impact factor: 11.205

Review 9.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

10.  The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport.

Authors:  Salem Faham; Akira Watanabe; Gabriel Mercado Besserer; Duilio Cascio; Alexandre Specht; Bruce A Hirayama; Ernest M Wright; Jeff Abramson
Journal:  Science       Date:  2008-07-03       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.